Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Author: Clinical Editor

Secondary use and scholarly impact of a portfolio of clinical trials with shared individual participant level data: cross sectional study

AbstractObjectiveTo assess the number, timing, characteristics, and scholarly impact of secondary publications generated using individual participant level data […]

September 3, 2026 Uncategorized

Sizing up the benefits of clinical trial data sharing

The potential benefits of sharing clinical trial data are broadly recognised by researchers, policy makers, and the public. […]

September 3, 2026 Uncategorized

Scotland’s health boards to be cut from 14 to two

Scotland’s 14 regional health boards will be replaced with two strategic health boards, first minister John Swinney has […]

September 3, 2026 Uncategorized

FDA approves Tivicay pd for youngest HIV patients

FDA approves Tivicay pd for youngest HIV patients
p p Read More

New treatment option expands paediatric HIV care access

September 3, 2026 News

Measles: CDC refuses to record Pennsylvania fatalities in “measles associated deaths” row

The US Centers for Disease Control and Prevention (CDC) has refused to include two measles associated deaths reported […]

September 3, 2026 Uncategorized

The Great ADHD Myth documentary is misleading and misinformed

In the Channel 4 documentary The Great ADHD Myth broadcast on 18 August 2026, psychiatrist and journalist Max […]

September 3, 2026 Uncategorized

Children as young as 6 are increasingly attending A&E in mental health crisis, analysis shows

Increasing numbers of young children are ending up in hospital emergency departments in a mental health crisis because […]

September 3, 2026 Uncategorized

Australia’s social media ban has not yet disrupted the status quo

This Opinion piece (BMJ 2026;393:e100046, doi:10.1136/bmj-2026-100046; published 24 June 2026) has been corrected to update the competing interests […]

September 2, 2026 Uncategorized

UK regulator plans to withdraw controversial vasculitis drug Tavneos over unreliable data

The Medicines and Healthcare Products Regulatory Agency (MHRA) has suspended the use and sale of Avacopan Vifor (also […]

September 2, 2026 Uncategorized

Koala trial doses first patient with novel KMA‑targeting CAR‑T

Koala trial doses first patient with novel KMA‑targeting CAR‑T
p p Read More

Australian teams advance first‑in‑human multiple myeloma therapy

September 2, 2026 News

Posts navigation

« Previous

Posts pagination

1 2 … 2,034 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy